121,156 Shares in Senseonics Holdings Inc (SENS) Acquired by Wesbanco Bank Inc.

Wesbanco Bank Inc. bought a new position in Senseonics Holdings Inc (NYSEAMERICAN:SENS) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 121,156 shares of the company’s stock, valued at approximately $314,000. Wesbanco Bank Inc. owned about 0.07% of Senseonics at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Bank of New York Mellon Corp lifted its position in Senseonics by 336.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 163,331 shares of the company’s stock worth $671,000 after buying an additional 125,908 shares in the last quarter. Schwab Charles Investment Management Inc. lifted its holdings in Senseonics by 153.4% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 213,261 shares of the company’s stock valued at $877,000 after purchasing an additional 129,089 shares during the last quarter. BlackRock Inc. lifted its holdings in Senseonics by 1,958.6% during the 2nd quarter. BlackRock Inc. now owns 3,811,007 shares of the company’s stock valued at $15,664,000 after purchasing an additional 3,625,877 shares during the last quarter. Renaissance Technologies LLC bought a new position in Senseonics during the 2nd quarter valued at about $2,285,000. Finally, Northern Trust Corp lifted its holdings in Senseonics by 797.6% during the 2nd quarter. Northern Trust Corp now owns 666,739 shares of the company’s stock valued at $2,740,000 after purchasing an additional 592,458 shares during the last quarter. Hedge funds and other institutional investors own 30.66% of the company’s stock.

NYSEAMERICAN SENS traded down $0.08 on Wednesday, hitting $2.31. 15,676 shares of the stock were exchanged, compared to its average volume of 1,303,517. Senseonics Holdings Inc has a 52 week low of $2.15 and a 52 week high of $5.29.

A number of equities analysts have weighed in on the stock. Zacks Investment Research downgraded shares of Senseonics from a “hold” rating to a “sell” rating in a research note on Wednesday, February 6th. Piper Jaffray Companies assumed coverage on shares of Senseonics in a research note on Tuesday, January 29th. They issued a “neutral” rating for the company. Finally, UBS Group assumed coverage on shares of Senseonics in a research note on Tuesday, November 27th. They issued a “sell” rating for the company. Two analysts have rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $6.00.

TRADEMARK VIOLATION WARNING: This report was first reported by Markets Daily and is owned by of Markets Daily. If you are accessing this report on another domain, it was stolen and reposted in violation of U.S. & international copyright legislation. The legal version of this report can be read at https://www.themarketsdaily.com/2019/02/13/121156-shares-in-senseonics-holdings-inc-sens-acquired-by-wesbanco-bank-inc.html.

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days.

Featured Article: How Do You Calculate Return on Investment (ROI)?

Institutional Ownership by Quarter for Senseonics (NYSEAMERICAN:SENS)

Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.